GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 16 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,000 | -60.0% | 10,045 | -25.8% | 0.00% | – |
| Q3 2018 | $15,000 | +15.4% | 13,530 | +5.8% | 0.00% | – |
| Q2 2018 | $13,000 | -7.1% | 12,788 | -5.5% | 0.00% | – |
| Q1 2018 | $14,000 | -73.1% | 13,527 | -30.4% | 0.00% | – |
| Q4 2015 | $52,000 | -26.8% | 19,449 | +44.3% | 0.00% | -100.0% |
| Q1 2015 | $71,000 | – | 13,477 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 28,437 | $30,000 | 0.01% |
| Virtu Financial LLC | 37,505 | $39,000 | 0.00% |
| Renaissance Technologies | 982,980 | $1,022,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 2,750 | $3,000 | 0.00% |
| JANE STREET GROUP, LLC | 13,527 | $14,000 | 0.00% |
| UBS Group AG | 3,398 | $3,000 | 0.00% |
| CITIGROUP INC | 300 | $0 | 0.00% |
| MORGAN STANLEY | 1,520 | $2,000 | 0.00% |
| Financial Architects, Inc | 350 | $0 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 12,000 | $12,000 | 0.00% |